Birth control options suffer from a huge gender imbalance, leaving women shouldering most of the load, and men with little besides condoms or a vasectomy to choose from. As a story in Bloomberg today reports, research in male contraception is experiencing a new wave of interest, including one scientist who is resurrecting a compound first investigated in an experiment on prisoners in the 1950's.
But as we have reported, funding for development of "the pill" for men still lags shockingly far behind programs that make contraception avialable to women. That's partly to do with the fact that safely stopping millions of sperm from being produced every day isn't as biologically straightforward as stopping one egg from being released each month. Still, there are researchers out there—not to mention a willing market—who want to help even the playing field, but they're going to need support in order to do it.
Maximize business value with data-driven strategies
Every organization is now collecting data, but few are truly data driven. Here are five ways data can transform your business.
Where to get abortion pills and how to use them
New US restrictions could turn abortion into do-it-yourself medicine, but there might be legal risks.
The book ban movement has a chilling new tactic: harassing teachers on social media
Educators who stand up to conservative activists are being harassed and called “groomers” online, turning them into potential targets for real-world violence.
OpenAI is ready to sell DALL-E to its first million customers
But the company has had to rush out fixes to the image-making model’s worst flaws to do so.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.